Many Americans are buying healthcare insurance that asks them to pay a lot, out-of-pocket, for the care they receive. It looks like that trend, towards higher expenses, is especially common among higher income folks, as shown by this picture courtesy of the Commonwealth Fund:
The Commonwealth Fund recently circulated information on the widespread difficulty many Americans have paying for their medical care, even when they have insurance. Burdened by high co-pays and high coinsurance rates, these out-of-pocket expenses are putting people on the financial edge. Here is a picture of the results, which show that a third of people…
Karen Vogt’s breast cancer journey began like many others, with her breasts painfully squeezed into a mammography machine. At age 52, it was far from her first mammogram, but this scan would be the most consequential by far. It revealed microcalcifications, little areas of breast tissue speckled with deposits of calcium that her radiologist worried…
Interesting picture on the Vox website from Sarah Kliff, showing an increase in the number of health insurance companies planning to compete on the exchanges next year: So much for the rumors that Obamacare will quickly kill the health insurance industry. (Click here to view comments)
I know why I sometimes eat too many brownies. They taste great! The same goes, of course, for a whole slew of desserts–I love me my strawberry rhubarb pie, and I never say no to a ginger snap. And while a touch of dessert is often a fine way to top off dinner, many of…
Rep. Raul Labrador (R-ID) speaks with members of the media at Trump Tower December 12, 2016 in New York. / AFP / KENA BETANCUR (Photo credit should read KENA BETANCUR/AFP/Getty Images) Back in May, an angry constituent asked Congressmen Raul Labrador why he voted for the Republican House Healthcare Bill, that the constituent claimed would…
In a previous post, I argued in favor of Rob Califf as FDA Commissioner. Here is an article from the Duke Chronicle, exploring more of this important debate. Dr. Robert Califf, former vice chancellor of clinical and translational research, may soon be taking helm of the U.S. Food and Drug Administration, but not without resistance from organizations…